Columbia-CZ team develops 10.3M parameter model that bests 100M parameter rivals on cell type classification
Discover GREmLN, a novel foundation model from Columbia and Chan Zuckerberg Biohub, that achieves superior cell-type classification with a compact design.| Drug Discovery and Development
